These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 17848286)
1. Stepwise progress in epidermal growth factor receptor/radiation studies for head and neck cancer. Harari PM Int J Radiat Oncol Biol Phys; 2007; 69(2 Suppl):S25-7. PubMed ID: 17848286 [TBL] [Abstract][Full Text] [Related]
2. Radiation combined with EGFR signal inhibitors: head and neck cancer focus. Harari PM; Huang S Semin Radiat Oncol; 2006 Jan; 16(1):38-44. PubMed ID: 16378905 [TBL] [Abstract][Full Text] [Related]
3. Targeting epidermal growth factor receptor in head and neck cancer: lessons learned from cetuximab. Moon C; Chae YK; Lee J Exp Biol Med (Maywood); 2010 Aug; 235(8):907-20. PubMed ID: 20562132 [TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor and response of head-and-neck carcinoma to therapy. Ang KK; Andratschke NH; Milas L Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):959-65. PubMed ID: 14967456 [TBL] [Abstract][Full Text] [Related]
5. Molecular-targeted therapies in the treatment of squamous cell carcinomas of the head and neck. Le Tourneau C; Siu LL Curr Opin Oncol; 2008 May; 20(3):256-63. PubMed ID: 18391623 [TBL] [Abstract][Full Text] [Related]
6. Cetuximab: an epidermal growth factor receptor monoclonal antibody for the treatment of colorectal cancer. Wong SF Clin Ther; 2005 Jun; 27(6):684-94. PubMed ID: 16117976 [TBL] [Abstract][Full Text] [Related]
7. Biology of interactions: antiepidermal growth factor receptor agents. Harari PM; Allen GW; Bonner JA J Clin Oncol; 2007 Sep; 25(26):4057-65. PubMed ID: 17827454 [TBL] [Abstract][Full Text] [Related]
8. Is there a role for cetuximab in non small cell lung cancer? Morgensztern D; Govindan R Clin Cancer Res; 2007 Aug; 13(15 Pt 2):s4602-5. PubMed ID: 17671149 [TBL] [Abstract][Full Text] [Related]
9. Established and emerging concepts in epidermal growth factor receptor biology. Grandis JR Int J Radiat Oncol Biol Phys; 2007; 69(2 Suppl):S22-4. PubMed ID: 17848285 [No Abstract] [Full Text] [Related]
10. Epidermal growth factor receptor inhibitors in cancer treatment: advances, challenges and opportunities. Modjtahedi H; Essapen S Anticancer Drugs; 2009 Nov; 20(10):851-5. PubMed ID: 19826350 [TBL] [Abstract][Full Text] [Related]
11. Recent advances in head and neck cancer therapy: the role of new cytotoxic and molecular-targeted agents. Caponigro F; Milano A; Basile M; Ionna F; Iaffaioli RV Curr Opin Oncol; 2006 May; 18(3):247-52. PubMed ID: 16552236 [TBL] [Abstract][Full Text] [Related]
12. The emerging role of cetuximab in head and neck cancer: a 2007 perspective. Panikkar RP; Astsaturov I; Langer CJ Cancer Invest; 2008 Feb; 26(1):96-103. PubMed ID: 18181051 [TBL] [Abstract][Full Text] [Related]
13. New molecular targeted therapies integrated with radiation therapy in lung cancer. Provencio M; Sánchez A; Garrido P; Valcárcel F Clin Lung Cancer; 2010 Mar; 11(2):91-7. PubMed ID: 20199974 [TBL] [Abstract][Full Text] [Related]
14. EGFR targeting drugs in the treatment of head and neck squamous cell carcinoma. Sundvall M; Karrila A; Nordberg J; Grénman R; Elenius K Expert Opin Emerg Drugs; 2010 Jun; 15(2):185-201. PubMed ID: 20415599 [TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor activation: how exon 19 and 21 mutations changed our understanding of the pathway. Rosell R; Taron M; Reguart N; Isla D; Moran T Clin Cancer Res; 2006 Dec; 12(24):7222-31. PubMed ID: 17189393 [TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor receptor biology in head and neck cancer. Kalyankrishna S; Grandis JR J Clin Oncol; 2006 Jun; 24(17):2666-72. PubMed ID: 16763281 [TBL] [Abstract][Full Text] [Related]